# To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

> **NCT00946725** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 28 (actual)

## Conditions studied

- Angina
- Hypertension

## Interventions

- **DRUG:** Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical)
- **DRUG:** Atenolol 100 mg Tablets (Geneva Pharmaceutical, Inc.)

## Key facts

- **NCT ID:** NCT00946725
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2000-11
- **Final completion:** 2000-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946725, "To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00946725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*